Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 190 of the 190 references it cites were found in a registry or an index; 201 of the 294 sources its claims cite were checked for support.

Current update on malaria in pregnancy: a systematic review

Open access
Minwuyelet, Awoke, Yewhalaw, Delenasaw, Siferih, Melkamu, Atenafu, Getnet · 2025 · Tropical Diseases, Travel Medicine and Vaccines

Abstract

BACKGROUND: Malaria during pregnancy poses significant risks to both the mother and the developing fetus. For pregnant women, the infection can result in severe illness and even death. Parasite sequestration in the placenta can cause maternal anemia and increase the risk of mortality both during and after childbirth. Malaria is also a major contributor to stillbirths and preterm births. Infected placental tissue can impede fetal growth, resulting in low birth weight, which is linked to delayed growth and cognitive development in the child. Furthermore, malaria during pregnancy remains a major contributor to perinatal, neonatal, and infant mortality. OBJECTIVES: To review the epidemiological patterns of malaria in pregnancy and its impact on maternal and neonatal health, and to analyze the availability and effectiveness of drug treatment options. METHODS: Relevant articles published only in English were searched using electronic databases such as PubMed, Web of Science, Scopus, and Pro-Quest. Keywords including "'malaria in pregnancy", "placental malaria", "congenital malaria", "treatment options", and "nutrition intervention and intermittent preventive treatment" were used in combination. Of the total of 4,486 articles identified, 139 articles were ultimately included. Whereas, others were excluded due to duplication, irrelevant abstract, title, and quality assessment. RESULTS: From 139 included studies, 47 focused on epidemiology of malaria in pregnancy, 58 on its impact and 16 on treatment options and 18 on nutrition intervention and intermittent treatment. Plasmodium falciparum is the leading cause of complications in pregnant women and is primarily found in Africa, while P.vivax is recognized as an emerging global threat, and causing serious consequences. Other species, such as P.knowlesi, P.ovale, and P.malariae are less common. Malaria prevalence in pregnancy can reach 60% in sub-Saharan Africa and 36% globally, with placental malaria affecting up to 28% of cases. The disease causes serious complications such as maternal anemia, premature birth, and low birth weight, severe anemia and increased maternal and infant mortality. Prevention strategies like intermittent preventive treatment (IPTp), insecticide-treated nets (ITNs) and Indoor residual spray (IRS) are essential. Early diagnosis and treatment can reverse adverse effects on placental and congenital function. Artesunate is recommended for severe malaria in all trimesters. Even resistance to chloroquine reported in some areas, it is the drug of choice for uncomplicated P.vivax infections. CONCLUSIONS: Malaria during pregnancy significantly impacts maternal and fetal health, leading to anemia, growth restriction, preterm birth, and neonatal death. Infants born to mothers with malaria are more likely to contract the disease. Further research and improved treatment strategies are needed to address this issue effectively.

Overview

CoChat Summary

TL;DR

This systematic review synthesizes 139 studies on malaria in pregnancy, covering epidemiology, maternal and neonatal impacts, treatment, and prevention. It reports that *P. falciparum* drives severe complications mainly in Africa while *P. vivax* is an emerging global threat, and that artesunate, IPTp-SP, ITNs, IRS, and nutritional supplementation are central management strategies.

Key findings

  • From 139 included studies, 47 addressed epidemiology, 58 addressed impact, 16 addressed treatment options, and 18 addressed nutrition intervention and intermittent preventive treatment. Malaria prevalence in pregnancy can reach 60% in sub-Saharan Africa and 36% globally, with placental malaria affecting up to 28% of cases.
  • *P. falciparum* is the leading cause of complications in pregnant women and is primarily found in Africa; *P. vivax* is recognized as an emerging global threat. Other species, such as *P. knowlesi*, *P. ovale*, and *P. malariae*, are less common.
  • Adverse outcomes include maternal anemia, premature birth, low birth weight, severe anemia, and increased maternal and infant mortality. Congenital malaria prevalence varied, for example Niger recorded 26.5% for *P. falciparum*, Uganda 6.1%, and Sudan 18.6–56.8% by PCR of cord blood samples.
  • Artesunate is recommended for severe malaria in all trimesters; chloroquine remains the drug of choice for uncomplicated *P. vivax* in some areas despite reported resistance. IPTp-SP with three or more doses reduced the risk of low birth weight by 56% compared with fewer than three doses in HIV-negative women.

Methods

  • PRISMA-based systematic review; searched PubMed, Web of Science, Scopus, and Pro-Quest using MeSH terms and text words including “malaria in pregnancy,” “placental malaria,” “congenital malaria,” “treatment options,” “nutrition interventions,” and “intermittent preventive treatment,” with filters English, Humans, female, from 2000/1/1 to 2024/12/12.
  • Two authors independently extracted data using a standardized JBI-modified form; two authors independently assessed quality with a nine-criterion JBI checklist adapted for prevalence studies. Studies scoring above 50% were included, while those scoring 50% or below were excluded.
  • The abstract reports 4,486 articles identified and 139 ultimately included; the results section reports an initial search yielding 4,269 publications, with 1,027 duplicates removed, 2,211 excluded on title/abstract, 892 removed after further screening, leaving 139 articles.

Limitations

  • Stated: only articles published exclusively in English peer-reviewed, open-access journals were included, potentially excluding relevant studies from non-peer-reviewed sources or grey literature. Exclusion of articles without full-text access, focusing on non-pregnant populations or non-malaria conditions, or lacking sufficient data may have omitted valuable data. These inclusion and exclusion criteria may have led to selection bias, limiting generalizability.
  • Evident: the abstract and results report different initial article counts (4,486 vs. 4,269), and the review presents a narrative/tabular synthesis without a meta-analysis.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s40794-025-00248-1

Cites

190 of 190 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 The flowchart of search and selection of articles for review of current update on malaria in pregnancy: A Systematic review
Fig. 1 The flowchart of search and selection of articles for review of current update on malaria in pregnancy: A Systematic reviewCC BY-NC-ND · PubMed Central
Fig. 2 Global epidemiology of malaria in pregnancy by Plasmodium species
Fig. 2 Global epidemiology of malaria in pregnancy by Plasmodium speciesCC BY-NC-ND · PubMed Central
Fig. 3 Prevalence of malaria in pregnancy based on WHO reports from 2000 to 2023
Fig. 3 Prevalence of malaria in pregnancy based on WHO reports from 2000 to 2023CC BY-NC-ND · PubMed Central
Fig. 4 The impact of malaria in pregnancy on maternal and fetal health
Fig. 4 The impact of malaria in pregnancy on maternal and fetal healthCC BY-NC-ND · PubMed Central
Fig. 5 Inflammatory responses and mRNA expression in maternal and placental malaria caused by P. vivax and P.falciparum
Fig. 5 Inflammatory responses and mRNA expression in maternal and placental malaria caused by P. vivax and P.falciparumCC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

105 Valid · 18 Not valid · 47 Not checked · 69 Own results and interpretations

102 more claims · 45 with their cited sources checked

Create a free account to see all 239 claims and to verify the 1 reference still open.

See all claims — free account
  • It may state two separate claims as one. 98
  • Probably not a substantial claim. 53
  • The quote only partly states this claim. 2

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

5 of 7 · the rest aren’t loaded

2 more findings

Create a free account to see every finding of this check.

See all findings — free account

Citations

Cites

Show all 186 references

Research works printed but not linked: 25

  1. Obeagu E, Obeagu G. Neonatal outcomes in children born to mothers with severe Malaria, HIV, and transfusion history: a review. Elite J Nurs Health Sci. 2024;2(3):38–58.
  2. Bôtto-Menezes C, Bardají A, Campos GDS, Fernandes S, Hanson K, Martínez-Espinosa FE, et al. Costs associated with malaria in pregnancy in the brazilian amazon, a low endemic area where Plasmodium vivax predominates. PLoS Negl Trop Dis. 2016;10(3):e0004494. · DOI
  3. Dombrowski JGR, Souza RMD, Regina NR, Silva M, Barateiro A, Epiphanio S, et al. Malaria during pregnancy and newborn outcome in an unstable transmission area in Brazil: a population-based record linkage study. PLoS ONE. 2018;13(6):e0199415. · DOI · Paper page
  4. Agudelo O, Arango E, Maestre A, Carmona-Fonseca J. Prevalence of gestational, placental and congenital malaria in north-west Colombia. Malar J. 2013;12:341. · DOI
  5. Khan WA, Galagan SR, Prue CS, Khyang J, Ahmed S, Ram M, et al. Asymptomatic Plasmodium falciparum Malaria in Pregnant Women in the Chittagong Hill Districts of Bangladesh. PLoS ONE. 2014;9(5):e9844. · DOI · Paper page
  6. Briand V, Hesran JYL, Mayxay M, Newton PN, Bertin G, Houzé S, et al. Prevalence of malaria in pregnancy in southern Laos: a cross-sectional survey. Malar J. 2016;15:436. · DOI
  7. Williams J, Njie F, Cairns M, Bojang K, Coulibaly SO, Kayentao K, et al. Non-falciparum malaria infections in pregnant women in West Africa. Malar J. 2016;15:53. · DOI · Paper page
  8. Unger HW, Rosanas-Urgell A, Robinson LJ, Ome-Kaius M, Jally S, Umbers AJ, et al. Microscopic and submicroscopic Plasmodium falciparum infection, maternal anaemia and adverse pregnancy outcomes in Papua New Guinea: a cohort study. Malarria J. 2019;18:302. · DOI · Paper page
  9. Gontie GB, Wolde HF, Baraki AG. Prevalence and associated factors of malaria among pregnant women in Sherkole district, Benishangul Gumuz regional state West Ethiopia BMC. Infect Dis. 2020;20:573.
  10. Feleke DG, Adamu A, Gebreweld A, Tesfaye M, Demisiss W, Molla G. Asymptomatic malaria infection among pregnant women attending antenatal care in malaria endemic areas of North-Shoa, Ethiopia: a cross-sectional study. Malar J. 2020;19:67. · DOI
  11. Solomon A, Kahase D, Alemayhu M. Prevalence of placental malaria among asymptomatic pregnant women in Wolkite health center, Gurage zone, Southern Ethiopia. Trop Dis Travel Med Vacc. 2020;6:20. · DOI
  12. Limenih A, Gelaye W, Alemu G. Prevalence of Malaria and associated factors among delivering mothers in Northwest Ethiopia. Hindawi BioMed Res Int. 2021;2021:7.
  13. Gemechu T, Dedecha W, Gelchu M, Husen O, Jarso H. Asymptomatic Malaria during pregnancy: prevalence, influence on anemia and associated factors in West Guji Zone, Ethiopia – a community-based study. Infect Drug Resist. 2023;16:6747–55. · DOI
  14. Carmona-Fonseca J, Eliana A, Maestre A. Placental Malaria in Colombia: histopathologic findings in plasmodium vivax and P. falciparum infections. Am J Trop Med Hyg. 2013;88(6):1093–101. · DOI · Paper page
  15. Poespoprodjo ER, Fobia W, Kenangalem E, Lampah DA, Warikar N, Seal A, et al. Adverse pregnancy outcomes in an area where multidrug resistant Plasmodium vivax and Plasmodium falciparum infections are endemic. Clin Infect Dis. 2008;46(9):1374–81. · DOI · Paper page
  16. Nosten F, McGready R, Simpson JA, Thwai KL, Balkan S, Cho T, et al. Effects of Plasmodium vivax malaria in pregnancy. Lancet Glob Health. 1999;354:546–9.
  17. Hegde A. Malaria in the intensive care Unit. Indian J Crit Care Med. 2021. https://doi.org/10.5005/jp-journals:10071-23871. · doi:10.5005/jp-journals:10071-23871
  18. Dombrowski JGR, Barateiro A, Peixoto EPM, Barros ABCudS, Souza MD, Clark TG, et al. Adverse pregnancy outcomes are associated with Plasmodium vivax malaria in a prospective cohort of women from the Brazilian Amazon. PLoS Negl Trop Dis. 2021;15(4):e0009390. · DOI · Paper page
  19. Dobaño C, Bardajı´ A, Are´valo-Herrera M, Espinosa FEMn, Boˆtto-Menezes C, Padilla N, et al. Cytokine signatures of Plasmodium vivax infection during pregnancy and delivery outcomes. PLoS Neglected Trop Dis 2020;14(5):e0008155. · DOI · Paper page
  20. Requena P, Rui E, Padilla N, MartõÂnez-Espinosa FE, Castellanos ME, tto-Menezes CB, et al. Plasmodium vivax VIR Proteins Are Targets of Naturally-Acquired Antibody and T Cell Immune Responses to Malaria in Pregnant Women. PLoS Neglected Tropical Diseases. 2016;10(10):e0005009. · DOI · Paper page
  21. Barnadas C, Tichit M, Bouchier C, Ratsimbasoa A, Randrianasolo L, Raherinjafy R, et al. Plasmodium vivax dhfr and dhps mutations in isolates from Madagascar and therapeutic response to sulphadoxine-pyrimethamine. Malar J. 2008;7:1–11. · DOI · Paper page
  22. Dellicour S, Tatem AJ, Guerra CA, Snow RW, Kuile FOT. Quantifying the number of pregnancies at risk of Malaria in 2007: a demographic study. PLoS Med. 2010;7(1):e1000221. · DOI · Paper page
  23. Dellicour S, Tatem AJ, Guerra CA, Snow RW, Kuile FOT. Quantifying the number of pregnancies at risk of Malaria in 2007: a demographic study. PLoS Med. 2007;7(1):e1000221. · DOI · Paper page
  24. Reddy V, Weiss DJ, Rozier J, Kuile FOT, Dellicou S. Global estimates of the number of pregnancies at risk of malaria from 2007 to 2020: a demographic study. Lancet Glob Health. 2023;11:e40-7. · DOI · Paper page
  25. Laochan N, Zaloumis SG, Imwong M, Lek-Uthai U, Brockman A, Sriprawat K, et al. Intervals to Plasmodium falciparum recurrence after anti-malarial treatment in pregnancy: a longitudinal prospective cohort. Malar J. 2015;14:1–9. · DOI

Cited by

See all 49

Metadata

Authors
Minwuyelet, A., Yewhalaw, D., Siferih, M., & Atenafu, G.
Affiliations
  • Debre Markos University (ET)
  • Jimma University (ET)
Corresponding author
Minwuyelet, Awoke
Venue
Tropical Diseases, Travel Medicine and Vaccines
Published
2025-05-22
Volume
11
Issue
1
Pages
14-14
ISSN
2055-0936 (ISSN-L)
OpenAlex
W4410553944
Cited by
49
References
186
Citations by year
2026: 40 · 2025: 8
FWCI
9.12
Type
journal article
Language
en
Open access
Licence
Locations
  • Tropical Diseases Travel Medicine and Vaccines (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Global Maternal and Child Health
  • Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
Keywords
malaria in pregnancy, placental malaria, congenital malaria, Plasmodium falciparum, Plasmodium vivax, anemia in pregnancy, low birth weight, preterm birth, stillbirth, neonatal mortality, intermittent preventive treatment, insecticide-treated nets, indoor residual spraying, artemisinin-based combination therapy, chloroquine resistance, malaria treatment, nutrition interventions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Current update on malaria in pregnancy: a systematic review. https://app.cochat.ai/papers/10.1186/s40794-025-00248-1
The paper
Minwuyelet, A., Yewhalaw, D., Siferih, M., & Atenafu, G. (2025). Current update on malaria in pregnancy: a systematic review. Tropical Diseases, Travel Medicine and Vaccines. https://doi.org/10.1186/s40794-025-00248-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.